Background This study aimed to investigate the prognostic impact of intratumoral Fusobacterium nucleatum in colorectal cancer (CRC) treated with adjuvant chemotherapy.
Methods F. nucleatumDNA was quantitatively measured in a total of 593 CRC tissues retrospectively collectedfrom surgically resected specimens of stage III or high-risk stage II CRC patients who had receivedcurative surgery and subsequent oxaliplatin-based adjuvant chemotherapy (either FOLFOXor CAPOX). Each case was classified into one of the three categories: F. nucleatum–high, –low, or –negative.
Results No significant differences in survival were observed between the F.nucleatum–high and –low/negative groups in the 593 CRCs (p = .671). Subgroup analyses accordingto tumor location demonstrated that disease-free survival was significantly better in F.nucleatum–high than in –low/negative patients with non-sigmoid colon cancer (including cecal,ascending, transverse, and descending colon cancers; n = 219; log-rank p = .026). In multivariateanalysis, F. nucleatum was determined to be an independent prognostic factor in non-sigmoidcolon cancers (hazard ratio, 0.42; 95% confidence interval, 0.18 to 0.97; p = .043). Furthermore,the favorable prognostic effect of F. nucleatum–high was observed only in a non-microsatellite instability-high (non-MSI-high) subset of non-sigmoid colon cancers (log-rank p = 0.014), but not ina MSI-high subset (log-rank p = 0.844), suggesting that the combined status of tumor locationand MSI may be a critical factor for different prognostic impacts of F. nucleatum in CRCs treatedwith adjuvant chemotherapy.
Conclusions Intratumoral F. nucleatum load is a potential prognosticfactor in a non-MSI-high/non-sigmoid/non-rectal cancer subset of stage II/III CRCs treatedwith oxaliplatin-based adjuvant chemotherapy.
Citations
Citations to this article as recorded by
Composition of the colon microbiota in the individuals with inflammatory bowel disease and colon cancer Ceren Acar, Sibel Kucukyildirim Celik, H. Ozgur Ozdemirel, Beril Erdem Tuncdemir, Saadet Alan, Hatice Mergen Folia Microbiologica.2024; 69(2): 333. CrossRef
Intratumoral microorganisms in tumors of the digestive system Mengjuan Xuan, Xinyu Gu, Yingru Liu, Li Yang, Yi Li, Di Huang, Juan Li, Chen Xue Cell Communication and Signaling.2024;[Epub] CrossRef
Prognostic impact of oral microbiome on survival of malignancies: a systematic review and meta-analysis Shuluan Li, Tianyu Wang, Ya Ren, Zhou Liu, Jidong Gao, Zhi Guo Systematic Reviews.2024;[Epub] CrossRef
Exploring the Potential of Humoral Immune Response to Commensal Bifidobacterium as a Biomarker for Human Health, including Both Malignant and Non-Malignant Diseases: A Perspective on Detection Strategies and Future Directions Kyogo Itoh, Satoko Matsueda Biomedicines.2024; 12(4): 803. CrossRef
Unveiling intratumoral microbiota: An emerging force for colorectal cancer diagnosis and therapy Jinjing Zhang, Penghui Wang, Jiafeng Wang, Xiaojie Wei, Mengchuan Wang Pharmacological Research.2024; 203: 107185. CrossRef
Spatial transcriptomic analysis reveals local effects of intratumoral fusobacterial infection on DNA damage and immune signaling in rectal cancer William P. Duggan, Batuhan Kisakol, Ina Woods, Mohammedreza Azimi, Heiko Dussmann, Joanna Fay, Tony O’Grady, Barry Maguire, Ian S. Reynolds, Manuela Salvucci, Daniel J. Slade, Deborah A. McNamara, John P. Burke, Jochen H.M. Prehn Gut Microbes.2024;[Epub] CrossRef
Gut microbiota characteristics of colorectal cancer patients in Hubei, China, and differences with cohorts from other Chinese regions Jianguo Shi, Hexiao Shen, Hui Huang, Lifang Zhan, Wei Chen, Zhuohui Zhou, Yongling Lv, Kai Xiong, Zhiwei Jiang, Qiyi Chen, Lei Liu Frontiers in Microbiology.2024;[Epub] CrossRef
The role of Fusobacterium nucleatum in cancer and its implications for clinical applications Wanyi Luo, Juxi Han, Xian Peng, Xuedong Zhou, Tao Gong, Xin Zheng Molecular Oral Microbiology.2024;[Epub] CrossRef
Gut Microbiome and colorectal cancer: discovery of bacterial changes with metagenomics application in Turkısh population Yakup Ulger, Anıl Delik, Hikmet Akkız Genes & Genomics.2024; 46(9): 1059. CrossRef
Intratumoral Microbiota: Metabolic Influences and Biomarker Potential in Gastrointestinal Cancer Xueyuan Bi, Jihan Wang, Cuicui Liu Biomolecules.2024; 14(8): 917. CrossRef
Intratumoral Microbiota: Insights from Anatomical, Molecular, and Clinical Perspectives Claudia Lombardo, Rosanna Fazio, Marta Sinagra, Giuseppe Gattuso, Federica Longo, Cinzia Lombardo, Mario Salmeri, Guido Nicola Zanghì, Carla Agata Erika Loreto Journal of Personalized Medicine.2024; 14(11): 1083. CrossRef
Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy Li Yang, Aitian Li, Ying Wang, Yi Zhang Signal Transduction and Targeted Therapy.2023;[Epub] CrossRef
Increased Fusobacterium tumoural abundance affects immunogenicity in mucinous colorectal cancer and may be associated with improved clinical outcome William P. Duggan, Manuela Salvucci, Batuhan Kisakol, Andreas U. Lindner, Ian S. Reynolds, Heiko Dussmann, Joanna Fay, Tony O’Grady, Daniel B. Longley, Fiona Ginty, Elizabeth Mc Donough, Daniel J. Slade, John P. Burke, Jochen H. M. Prehn Journal of Molecular Medicine.2023; 101(7): 829. CrossRef
Fusobacterium nucleatum Load Correlates with KRAS Mutation and Sessile Serrated Pathogenesis in Colorectal Adenocarcinoma Koki Takeda, Minoru Koi, Yoshiki Okita, Sija Sajibu, Temitope O. Keku, John M. Carethers Cancer Research Communications.2023; 3(9): 1940. CrossRef
La asociación entre Fusobacterium nucleatum y el cáncer colorrectal: una revisión sistemática y metaanálisis Paola Villar-Ortega, Manuela Expósito-Ruiz, Miguel Gutiérrez-Soto, Miguel Ruiz-Cabello Jiménez, José María Navarro-Marí, José Gutiérrez-Fernández Enfermedades Infecciosas y Microbiología Clínica.2022; 40(5): 224. CrossRef
The association between Fusobacterium nucleatum and cancer colorectal: A systematic review and meta-analysis Paola Villar-Ortega, Manuela Expósito-Ruiz, Miguel Gutiérrez-Soto, Miguel Ruiz-Cabello Jiménez, José María Navarro-Marí, José Gutiérrez-Fernández Enfermedades infecciosas y microbiologia clinica (English ed.).2022; 40(5): 224. CrossRef
Suppression of Berberine and Probiotics (in vitro and in vivo) on the Growth of Colon Cancer With Modulation of Gut Microbiota and Butyrate Production Chao Huang, Ying Sun, Sheng-rong Liao, Zhao-xin Chen, Han-feng Lin, Wei-zeng Shen Frontiers in Microbiology.2022;[Epub] CrossRef
Prognostic and clinicopathological significance of Fusobacterium nucleatum in colorectal cancer: a systemic review and meta-analysis Younghoon Kim, Nam Yun Cho, Gyeong Hoon Kang Journal of Pathology and Translational Medicine.2022; 56(3): 144. CrossRef
Iron accelerates Fusobacterium nucleatum–induced CCL8 expression in macrophages and is associated with colorectal cancer progression Taishi Yamane, Yohei Kanamori, Hiroshi Sawayama, Hiromu Yano, Akihiro Nita, Yudai Ohta, Hironori Hinokuma, Ayato Maeda, Akiko Iwai, Takashi Matsumoto, Mayuko Shimoda, Mayumi Niimura, Shingo Usuki, Noriko Yasuda-Yoshihara, Masato Niwa, Yoshifumi Baba, Taka JCI Insight.2022;[Epub] CrossRef
Clinicopathological differences of high Fusobacterium nucleatum levels in colorectal cancer: A review and meta-analysis Yi Wang, Yuting Wen, Jiayin Wang, Xin Lai, Ying Xu, Xuanping Zhang, Xiaoyan Zhu, Chenglin Ruan, Yao Huang Frontiers in Microbiology.2022;[Epub] CrossRef
Clinical Significance of Fusobacterium nucleatum and Microsatellite Instability in Evaluating Colorectal Cancer Prognosis Yanxuan Xie, Xiaoyang Jiao, Mi Zeng, Zhiqiang Fan, Xin Li, Yumeng Yuan, Qiaoxin Zhang, Yong Xia Cancer Management and Research.2022; Volume 14: 3021. CrossRef
Influence of the Microbiome Metagenomics and Epigenomics on Gastric Cancer Precious Mathebela, Botle Precious Damane, Thanyani Victor Mulaudzi, Zilungile Lynette Mkhize-Khwitshana, Guy Roger Gaudji, Zodwa Dlamini International Journal of Molecular Sciences.2022; 23(22): 13750. CrossRef
Circulating IgA Antibodies Against Fusobacterium nucleatum Amyloid Adhesin FadA are a Potential Biomarker for Colorectal Neoplasia Jung Eun Baik, Li Li, Manish A. Shah, Daniel E. Freedberg, Zhezhen Jin, Timothy C. Wang, Yiping W. Han Cancer Research Communications.2022; 2(11): 1497. CrossRef
Differential immune microenvironmental features of microsatellite-unstable colorectal cancers according to Fusobacterium nucleatum status Ji Ae Lee, Seung-Yeon Yoo, Hyeon Jeong Oh, Seorin Jeong, Nam-Yun Cho, Gyeong Hoon Kang, Jung Ho Kim Cancer Immunology, Immunotherapy.2021; 70(1): 47. CrossRef
Fusobacterium nucleatum and Clinicopathologic Features of Colorectal Cancer: Results From the ColoCare Study Yannick Eisele, Patrick M. Mallea, Biljana Gigic, W. Zac Stephens, Christy A. Warby, Kate Buhrke, Tengda Lin, Juergen Boehm, Petra Schrotz-King, Sheetal Hardikar, Lyen C. Huang, T. Bartley Pickron, Courtney L. Scaife, Richard Viskochil, Torsten Koelsch, A Clinical Colorectal Cancer.2021; 20(3): e165. CrossRef
Role of gut microbiota in epigenetic regulation of colorectal Cancer Yinghui Zhao, Chuanxin Wang, Ajay Goel Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2021; 1875(1): 188490. CrossRef
Fusobacterium nucleatum: caution with interpreting historical patient sample cohort Kate L. F. Johnstone, Sinead Toomey, Stephen Madden, Brian D. P. O’Neill, Bryan T Hennessy Journal of Pathology and Translational Medicine.2021; 55(6): 415. CrossRef
Fusobacterium nucleatum colonization is associated with decreased survival of helicobacter pylori-positive gastric cancer patients Yung-Yu Hsieh, Shui-Yi Tung, Hung-Yu Pan, Te-Sheng Chang, Kuo-Liang Wei, Wei-Ming Chen, Yi-Fang Deng, Chung-Kuang Lu, Yu-Hsuan Lai, Cheng-Shyong Wu, Chin Li World Journal of Gastroenterology.2021; 27(42): 7311. CrossRef
Analysis of changes in microbiome compositions related to the prognosis of colorectal cancer patients based on tissue-derived 16S rRNA sequences Sukjung Choi, Jongsuk Chung, Mi-La Cho, Donghyun Park, Sun Shim Choi Journal of Translational Medicine.2021;[Epub] CrossRef
Gastrointestinal tumors and infectious agents: A wide field to explore Miriam López-Gómez, Belén García de Santiago, Pedro-David Delgado-López, Eduardo Malmierca, Jesús González-Olmedo, César Gómez-Raposo, Carmen Sandoval, Pilar Ruiz-Seco, Nora Escribano, Jorge Francisco Gómez-Cerezo, Enrique Casado World Journal of Meta-Analysis.2021; 9(6): 505. CrossRef
Gut Microbiota Profiles in Early- and Late-Onset Colorectal Cancer: A Potential Diagnostic Biomarker in the Future Murdani Abdullah, Ninik Sukartini, Saskia Aziza Nursyirwan, Rabbinu Rangga Pribadi, Hasan Maulahela, Amanda Pitarini Utari, Virly Nanda Muzellina, Agustinus Wiraatmadja, Kaka Renaldi Digestion.2021; 102(6): 823. CrossRef
The effect of periodontal bacteria infection on incidence and prognosis of cancer Li Xiao, Qianyu Zhang, Yanshuang Peng, Daqing Wang, Ying Liu Medicine.2020; 99(15): e19698. CrossRef
The impact of the gut microbiota on prognosis after surgery for colorectal cancer – a systematic review and meta‐analysis Emilie Palmgren Colov, Thea Helene Degett, Hans Raskov, Ismail Gögenur APMIS.2020; 128(2): 162. CrossRef
Can the microbiota predict response to systemic cancer therapy, surgical outcomes, and survival? The answer is in the gut Khalid El Bairi, Rachid Jabi, Dario Trapani, Hanae Boutallaka, Bouchra Ouled Amar Bencheikh, Mohammed Bouziane, Mariam Amrani, Said Afqir, Adil Maleb Expert Review of Clinical Pharmacology.2020; 13(4): 403. CrossRef
Predictive Values of Colon Microbiota in the Treatment Response to Colorectal Cancer Jorge Galan-Ros, Verónica Ramos-Arenas, Pablo Conesa-Zamora Pharmacogenomics.2020; 21(14): 1045. CrossRef
The gut microbiome and potential implications for early-onset colorectal cancer Reetu Mukherji, Benjamin A Weinberg Colorectal Cancer.2020;[Epub] CrossRef
Fusobacterium nucleatum in the Colorectum and Its Association with Cancer Risk and Survival: A Systematic Review and Meta-analysis Christian Gethings-Behncke, Helen G. Coleman, Haydee W.T. Jordao, Daniel B. Longley, Nyree Crawford, Liam J. Murray, Andrew T. Kunzmann Cancer Epidemiology, Biomarkers & Prevention.2020; 29(3): 539. CrossRef
CpG Island Methylation in Sessile Serrated Adenoma/Polyp of the Colorectum: Implications for Differential Diagnosis of Molecularly High-Risk Lesions among Non-dysplastic Sessile Serrated Adenomas/Polyps Ji Ae Lee, Hye Eun Park, Seung-Yeon Yoo, Seorin Jeong, Nam-Yun Cho, Gyeong Hoon Kang, Jung Ho Kim Journal of Pathology and Translational Medicine.2019; 53(4): 225. CrossRef
Fusobacterium nucleatum tumor DNA levels are associated with survival in colorectal cancer patients Andrew T. Kunzmann, Marcela Alcântara Proença, Haydee WT Jordao, Katerina Jiraskova, Michaela Schneiderova, Miroslav Levy, Václav Liska, Tomas Buchler, Ludmila Vodickova, Veronika Vymetalkova, Ana Elizabete Silva, Pavel Vodicka, David J. Hughes European Journal of Clinical Microbiology & Infectious Diseases.2019; 38(10): 1891. CrossRef
Gut Microbiome: A Promising Biomarker for Immunotherapy in Colorectal Cancer Sally Temraz, Farah Nassar, Rihab Nasr, Maya Charafeddine, Deborah Mukherji, Ali Shamseddine International Journal of Molecular Sciences.2019; 20(17): 4155. CrossRef
The Four Horsemen in Colon Cancer Marco Antonio Hernández-Luna, Sergio López-Briones, Rosendo Luria-Pérez Journal of Oncology.2019; 2019: 1. CrossRef
The role of Fusobacterium nucleatum in colorectal cancer: from carcinogenesis to clinical management Chun‐Hui Sun, Bin‐Bin Li, Bo Wang, Jing Zhao, Xiao‐Ying Zhang, Ting‐Ting Li, Wen‐Bing Li, Di Tang, Miao‐Juan Qiu, Xin‐Cheng Wang, Cheng‐Ming Zhu, Zhi‐Rong Qian Chronic Diseases and Translational Medicine.2019; 5(3): 178. CrossRef